Algo version: 0.98b
iShares Neuroscience and is listed at the AMEX Exchange
iShares Neuroscience and [IBRN]
AMEX Sector: Financial Services Industry:Asset Management

Is iShares Neuroscience and stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, iShares Neuroscience and pays dividends. Last time was Wednesday 27th of December 2023 where the investors holding the stock on Wednesday 20th of December 2023 were paid $0.006303 per share. Over the last 2 times between 2023 and 2023, iShares Neuroscience and has paid $0.014544 with an average of $0.01 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for iShares Neuroscience and 10 years ago, but if you had invested on Friday 26th of August 2022 when the price was $24.57, you would have made a profit of $1.420 per share or 5.78%

No, the average daily trading liquidity for iShares Neuroscience and is $629 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

iShares Neuroscience and has no real debt, which is good in periods of high inflation. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for iShares Neuroscience and to be medium [0.6 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.